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Abstract: Establishing methods to investigate treatments that induce cell death in parasitic nema-
todes will promote experimental approaches to elucidate mechanisms and to identify prospective
anthelmintics capable of inducing this outcome. Here, we extended recent progress on a method to
monitor cell death and to identify small molecule inhibitors in Ascaris suum to Haemonchus contortus,
a phylogenetically distant parasitic nematode of significance for both human and agricultural animal
health. We utilized a diverse group of small molecule inhibitors referred to as nematode intestinal
toxins/toxicants (NITs) coupled with motility, cytological and cell death assays to resolve gross
effects on motility and individual cells and organ systems of two H. contortus larval stages in cul-
ture. Early transcriptional response evaluation identified NIT-responsive genes and pathways. The
scope of death among cells in larvae varied among NITs but shared patterns with A. suum, despite
the approach having some limitations due to characteristics of H. contortus larvae. Gene response
patterns varied among NITs tested and provided information on the cell targets and pathways
affected. Experimental NIT assays provide tools capable of inducing cell death in larval stages of
parasitic nematodes, and can resolve many individual cells and organ systems in which cell death
can be induced.
Keywords: nematode; intestine; anthelmintics; microscopy; pathology; RNA-seq
1. Introduction
Parasitic nematodes cause diseases that produce substantial mortality and morbidity
among humans across the globe. These pathogens also reduce food production in livestock
and plants that, in turn, differentially restricts the nutritional resources of the global
population with the lowest incomes. Anthelmintic treatments are heavily relied upon in
efforts to control and treat infections caused by nematode pathogens. Impeding these efforts
is the limited selection of efficacious anthelmintics coupled with emerging anthelmintic
resistance among these pathogens [1]. While the situation identifies a need to expand the
number and kind of available anthelmintics, technical advances that enhance research
capabilities are also needed to accelerate the accomplishment of this goal.
To advance research on anthelmintics and experimental capabilities on nematode
pathogens, we established an approach with a design for pan-Nematoda applications that
has a primary focus on a single-parasite tissue, the intestine. The rationale for this focus
relates mainly to its apparent hypersensitivity to some anthelmintics and relative tractability
to experimental approaches compared with other tissues, as described elsewhere [2].
Capitalizing on a pan-Nematoda multiomics database for the intestine, combined with
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other biologic and pharmacological considerations, we experimentally derived a set of
drug-like molecules referred to as nematode intestinal toxins/toxicants (NITs). Each NIT
caused pathology in intestinal cells of larval stages and, in some cases, adult worms of
Ascaris suum, a model species to study the intestine of parasitic nematode species [3]. The
identification of potential inhibitors of secretory processes was the organizing principle
for the de novo identification of NITs, and multiple NITs demonstrated efficacy against
phylogenetically diverse nematode species representing whipworms (Clade I), filarial
worms (Clade III), and C. elegans (Clade V) [3].
Cellular proteins annotated as targets for each NIT collectively identify a diverse
set of potential target proteins of significance in A. suum intestinal cells [4]. Although
new approaches to kill nematode intestinal cells was a goal of this research, expression
in other tissues was expected for many of the potential target proteins. In this context,
an approach was developed to rapidly determine the range of cells induced to undergo
cell death by experimental treatments, such as NITs, in whole A. suum larvae in culture.
Information of this kind can augment that obtained for prospective anthelmintics identified
by using motility assays. The assay utilized propidium iodide (PI), a DNA-binding vital
dye to detect the end point of cell death in whole nematodes in culture. Assignment
of death to specific cells and organs was facilitated by anatomic details established by
using a combination of the cell permeable DNA-binding dye, bisbenzimide (BB), and
differential interference contrast (DIC) microscopy. The method rapidly resolved cell death
in numerous cells/organs (e.g., intestine, nervous system, excretory system, seam cells,
hypodermal cells, and others) of live larvae while in culture, and the results highlighted
differences among cell death profiles induced by NITs. Thus, NITs represent tools to
investigate cellular mechanisms leading to death in many cells of parasitic nematodes,
and the PI cell death assay provides a read out for related experimental manipulations in
this context. Related applications have been achieved with the non-parasitic nematode
Caenorhabditis elegans [5,6].
Components of early gene response patterns (GRPs) induced by NITs may reflect
elements of pathways involved with initiating or mediating cell death responses. RNA-
seq analysis following treatment with NITs identified early GRPs in A. suum larvae that
informed on potential target proteins and pathways (e.g.,dihydroorotate dehydrogenase
(uridine synthesis) and RAB GTPase(s) (vesicle transport)) that may relate to initiator
events leading to cell death induced by selected NITs [4]. Information of this kind can
aid in the design of experiments to manipulate cell death outcomes initiated by NITs and
assessed by the PI cell death assay.
The overall design of our larger research effort was intended to advance knowledge
in a pan-Nematoda context involving three phylogenetically diverse parasitic species,
each with distinct evolutionary pathways to parasitism (Haemonchus contortus, clade V;
A. suum, clade III; and Trichuris suis, clade I). These three species were used for the initial
computational prioritization of NITs [3], and they collectively represent much of the
phylogenetic distance in the Nematoda, which includes parasites of many species including
humans, animals, and plants (where parasitism is defined as requiring a host to complete
at least one stage of its life cycle, as opposed to non-parasitic “free-living” species such as
C. elegans which does not infect any hosts [7]). Although A. suum figured centrally in the
development of this pan-Nematoda approach [3,4], we here sought to determine if NITs and
the PI cell death assay have applications to rapidly detect death induced by NITs in cells
and organs of H. contortus, leaving T. suis the only one of the three for which applications
have yet to be investigated. H. contortus, an abomasal parasite of small ruminants, was
chosen due to its veterinary importance and a number of experimental advantages it offers,
including availability of large numbers of infective L3 and the ability to culture exsheathed
L3 (xL3) to “parasitic” L4s. H. contortus feeds on blood and is one of the most detrimental
pathogens of small ruminants, which are important resources for nutrition and commerce
in many developing regions of the world [8–10]. The propensity of H. contortus to rapidly
acquire anthelmintic resistance makes advances to control this parasite highly important.
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Thus, new tools and biological knowledge related to cellular effects of experimental toxins
may promote advances in anthelmintic research on H. contortus. Although PI has been
used in a general application to monitor anthelmintic effects on H. contortus larvae [11],
resolution of individual cells and organs relative to cell death outcomes and nuances of a
system to do so have not.
In research reported here, we sought to determine if NITs are toxic to H. contortus
larval stages, if they cause cell death detectable by the PI assay, the identity of cells
and organs that are susceptible to NIT-induced cell death, and the GRPs affected early
by selected NIT treatments. The results indicated that, even with limitations stemming
from interspecies biological differences, the approach has applications to H. contortus,
providing new pathological and molecular tools that can be integrated into research on this
model species, the progress of which will contribute to the study of nematode pathogens
of humans.
2. Results
Results from a PI-based cell death assay and GRPs can augment insights provided by
whole-worm motility inhibition assays that are commonly used to evaluate effects of drugs
and drug-like compounds on parasitic nematodes. The rapid resolution of individual cells
and organs affected by these treatments in live worms greatly enhances details of likely
relevance to the anthelmintic effects at play, as was demonstrated in our previous studies
in the nematode clade III parasite, A. suum [3,4]. In this investigation, we explored the
utility of the overall experimental approach to another parasitic species, H. contortus, a
clade V parasite. That system involves the use of (i) fluorescent nuclear probes (propidium
iodide and bisbenzimide), (ii) an H. contortus larval culture system, and (iii) RNA-seq
GRPs to treatments. The system was demonstrated using our set of six (seven, with this
research) small-molecule inhibitors recently demonstrated to target the nematode intestine
(nematode intestinal toxins/toxicants, NITs [3]).
2.1. Fluorescent Probes Demonstrate Larval Ingestion
Two different function-based fluorescent probes were utilized to assess ingestion by
H. contortus xL3 and L4 larvae: (1) beta-ala,lys-AMCA (BAL-AMCA), a fluorescent dipep-
tide that enters nematode intestinal cells by receptor-mediated transport [12] (Figure 1A,B);
and (2) DQ-Bovine serum albumin (DQ-BSA), a protease substrate that is fluorescence
quenched in the intact construct and becomes visible upon proteolytic hydrolysis [13]
(Figure 1C,D). We found that a mean 74.0% and 84.5% of H. contortus L4, respectively, were
positive for signal in the intestinal tract after 4 h when cultured with these probes, while
neither probe was detected in the intestines of xL3s (Figure 1E), confirming differences
in competence to feed by each of these respective stages under conditions utilized in
these experiments.
2.2. NIT Effects on H. contortus Motility
In past research, the effects of six nematode intestinal toxins/toxicants (NITs) were
reported for A. suum L3 and L4 larvae (staurosporine, ruxolitinib, leflunomide, sunitinib,
alvocidib, and CID1067700) [3,4]. A seventh NIT not previously reported (p38 MAP kinase
inhibitor IV, also known as MT4) was identified through the same de novo process as in
Jasmer et al., 2020 [3] and is a prospective inhibitor of p38 MAP kinases. MT4 showed
activity against A. suum L3 and L4 in motility assays (Figure 2) and had an IC50 of 55.6 µM
after 24 h in L3, and 92.2 µM after 24 h in L4. Similar to other NITs, MT4 caused damage to
A. suum L3 intestinal cells observable by DIC microscopy in which disruption of intestinal
cells and cell membranes was evident. Live larvae were labeled with a cell-permeable
DNA-binding dye (bisbenzimide, BB) to visualize intestinal cell nuclei, and BB-labeled
intestinal cell nuclei in whole L3 showed a disrupted pattern consistent with cell membrane
damage. Thus, MT4 meets our definition of a NIT (>70% inhibition at day 4 with the highest
dose [3]), coupled with the demonstrated pathology observed in intestinal cells. Because of
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its relative effectiveness compared to other NITs, MT4 it was included as a seventh NIT in
experiments conducted with H. contortus.
Figure 1. Fluorescent probes demonstrate larval ingestion in L4 H. contortus. Beta-ala,lys-AMCA
(BAL-AMCA) (A), or DQ-Bovine Serum Albumin (DQ-BSA) (C) labeled larvae shows probe staining
in the intestine. Unlabeled controls (B,D), respectively) larvae lack staining. (E) The proportion of
xL3 and L4 larvae with staining by each probe after 4 h incubation.
Each of the seven NITs was initially tested with a single concentration on xL3 and
L4. In general, xL3s showed less sensitivity than L4s to all of the NITs at the highest
concentrations used for each, with the exceptions of MT4 which reached full efficacy faster
in the xL3 stage, and leflunomide which was 100% effective after 1 day in both stages
(Figure 3). Because xL3s are developmentally positioned at the transition to the parasitic
phase of the life cycle, our efforts focused to determine IC50 values for L4, which, although
produced in vitro, are expected to better represent the parasitic phase of the life cycle
(Figure 3). Each NIT caused a significant decrease of motility for H. contortus L4 at some
concentration within the range tested, and the relative effectiveness was ordered according
to IC50 (Figure S1). As with A. suum, staurosporine was by far the most effective, with an
IC50 of just 2.37 µM after 1 day, and the testing being performed at a lower concentration
compared with the other NITs. The newly-added NIT MT4 was the second-most effective,
with an IC50 of 56.7 µM after 1 day, followed by ruxolitinib with an IC50 of 221.4 µM
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after 1 day, but dropping below 31.3 µM by day 2. As with A. suum [3], leflunomide was
highly effective at higher concentrations (>250 µM) but was not very effective at lower
concentrations. Sunitinib only became effective after 4 days of treatment, while alvocidib
and the intestinocentric CID1067700 did not show substantial effects on motility in this
assay. In general, these results extended the application of these NITs to include H. contortus
xL3 and/or L4 relative to research on cellular mechanisms and targets responsible for
anthelmintic effects on them.
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Figure 2. MT4 treatment on A. suum larvae. Motility assay results are shown for (A) L3-stage larvae
(IC50 55.5 µM at 24 h) and (B) L4-stage larvae (IC50 91.4 µM at 24 h). (C) 2-day untreated control
L3 larvae viewed with 60× differential interference contrast (DIC) microscopy (left) shows intact
intestinal cells and (D) BB nuclear-staining shows a normal pattern of intestinal nuclei. Treatment
with MT4 (500 µM) for 2 days induces (E) visible destruction of intestinal cells and (F) disrupted
patterning of intestinal nuclei.
2.3. Live H. contortus xL3 and L4 Nuclei Localization by Bisbenzimide (BB) Labeling
As with A. suum, we labeled live larvae with BB to monitor nuclei localization in
healthy and NIT-treated larvae. The ability of BB to penetrate and label nuclei of live xL3
and L4 was first determined for larvae in culture wells (96 well plate) and viewed using a
20× objective (200× magnification) on an inverted microscope. The images showed larvae
(Figures 4A and 4B) with a subset of nuclei that were clearly labeled with BB, whereas it
was also evident that many nuclei went unlabeled (clarified in the next section). Because of
this incomplete staining profile, the images were taken after 16 h exposure to BB in culture
in attempts to maximize staining. Periodic observation over longer periods of time did
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not show any improvement on this pattern of staining. The general pattern of BB nuclear
staining was similar for live xL3 and L4. Because of the relatively small size of H. contortus
larvae (approximately 1/2 to 1/3 of the length and width of A. suum) and the incomplete
BB staining profile, it was difficult to assign stained nuclei more specifically to organs or
cells based on information gained at this magnification.
Figure 3. Motility assay results for H. contortus xL3 (single concentration) and L4 (dilution series) nematode intestinal
toxins/toxicants (NIT) treatments, including staurosporine (IC50 of 2.37 µM, 1 day), MT4 (56.7 µM, 1 day), ruxolitinib
(221.5 µM, 1 day), leflunomide (L4-stage IC50 192.9 µM after 1 day), sunitinib (161.5 µM, 2 days), alvocidib (427.0 µM,
3 days), and CID1067700 (215.1 µM, 4 days).
Further specificity on the assignment of BB labeled nuclei was gained using DIC coupled
with fluorescent microscopy at 600× magnification (Figure 4C–J). In general, DIC resolution of
tissues and cells was compromised for H. contortus larvae over much of the body posterior to
the esophagus due in part to refractive granules located predominantly in intestinal cells. For
reasons that are unclear, intact H. contortus larvae also often produced relatively poor contrast
under DIC conditions used here, impeding the resolution of cells. Despite these two limitations,
a range of cells could be discerned, including cells and nuclei located where neurons have
been documented anterior and posterior to the nerve ring in H. contortus and/or C. elegans
research [14,15], lateral chords with associated seam cells (multipotent lateral hypodermal cells
which lie along each side of the worm [16]; Figure 4E,F), ventrally located nuclei that represent
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presumptive hypodermal and neuronal nuclei associated with the ventral chord (Figure 4G,H),
the intestine (Figure 4I,J), and cells comprising the posterior tail region (Figure 4E, likely to
include hypodermal, neuronal, muscle nuclei), as is found in C. elegans. The ventral location of
apparent hypodermal nuclei is similar to C. elegans [17], but different from A. suum larvae in
which they associate with the lateral chord [4].
Figure 4. Bisbenzimide (BB) nuclear staining resolves tissues and cells in H. contortus larvae. xL3
(A) and L4 (B) larvae have similar BB staining profiles across the worm. L4 larval nuclei anterior
to the nerve ring (ANR) visible by DIC (C) stain with BB (D), while most of those posterior to the
nerve ring (PNR) do not stain, despite the presence of cells. Along the length of the lateral chord
to the tail visible by DIC (E), seam cell and tail cell nuclei are visible by BB (F). Cells visible on the
lateral side of the larva by DIC (G) contain several ventral hypodermal/neuronal nuclei stained with
BB (H). Staggered intestinal cell nuclei visible by DIC (I) are visible by BB (J). Panel A is viewed
with a 20× objective (200× magnification), and the remaining panels (L4 larvae) are viewed with
60× objective (600× magnification) and cropped/magnified digitally to highlight features. BB was
incubated for 4 h pre-treatment and was included throughout the incubation period. DIC images
have been adjusted for brightness and contrast individually to best highlight features of interest.
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Following structural clarification from DIC examination, prominent areas and cells
that were routinely observed with BB labeling (results only shown for L4) included nuclei
anterior to the nerve ring, cells in the lateral chord (presumptive seam cells), and cells in
the posterior tail region of larvae. Nuclei from prominent organs in which BB labeling was
routinely absent, or more variable, included those of apparent neurons posterior to the
nerve ring, intestinal cells, esophageal cell, muscle cells, and most ventral chord nuclei
(Figure 4). The BB-labeled intestinal cell nuclei shown in Figure 4J were an uncommon
finding and were included to show the staggered appearance of those nuclei along the
longitudinal axis of the larvae (useful for assessing cell death, see next section). BB staining
of ventral chord nuclei was more sporadic with many often unstained by BB (Figure 4H).
Features necessary to differentiate between the ventral neuronal and hypodermal nuclei
were not evident with available details, and thus the variability could reflect preferential
staining of either cell type or combinations of both.
To summarize, DIC microscopy coupled with BB labeling aided in resolution of
many nuclei, cells, and organ systems in H. contortus xL3 and L4. The observations
provide a baseline to better interpret cell death results illuminated by PI in the next section.
However, characteristics that impeded resolution of anatomic detail by DIC or prevented
broad cellular penetration and nuclear staining of BB presented notable limitations of
this approach in the context of H. contortus larvae, compared with previous work with
A. suum [4]. Although DIC coupled with fluorescence microscopy resolved useful anatomic
details, this method is cumbersome and unreliable for efficient quantitative assessment of
larvae affected in replicates of experimental treatments. In contrast, the inverted microscope
supports quantitative assessments of larvae in wells of culture plates, but provides less
anatomic detail. Consequently, the two approaches are complementary for extracting
information on the larval stages investigated.
2.4. Propidium Iodide (PI) Detection of Cell Death in H. contortus xL3 and L4
As in a previous study in A. suum [4], PI staining assays were performed to determine
if NIT treatments can induce cell death, to identify the range of cells that can be induced
to undergo cell death in larvae (L4), and to compare different NIT characteristics that are
identifiable by PI staining. The highest concentration of each NIT used in motility assays
(500 µM for all except staurosporine at 25 µM) was used to ensure positive results. Images of
PI-stained larvae were recorded after 2 days of treatment for each NIT (Figure 5). In many, but
not all cases, the small size of H. contortus larvae often compromised resolution and assignment
of staining to specific cells and organ systems. Therefore, images presented are an attempt
at representing the most common patterns for each NIT. For example, leflunomide induced
general PI labeling in most worms (Figure 5D). Although it is difficult to identify many of
the cells affected, it seems safe to conclude that leflunomide causes cell death in many, if not
all, cells and organs of these larvae, inclusive of neurons posterior to the nerve ring that were
refractory to BB labeling in live larvae. Hence, susceptibility to pharmacologic induction of
cell death extends to many cells and organs of H. contortus L4s. Most other NITs caused more
restricted PI staining patterns, several of which identified the staggered appearance of intestinal
cell nuclei (Figure 5A,F,G), others included apparent seam cell nuclei, while others produced a
PI staining pattern consistent with ventral chord cells (hypodermal, neuronal, or nuclei of both;
Figure 5C). Although PI staining of genital primordia was observed in some treatments, this
effect was most obvious for MT4-treated larvae (Figure 5B), whereas the broad PI staining in
leflunomide treatments often obscured genital primordia for assessment. In contrast with NIT
treatments, control larvae generally showed very little background PI staining (Figure 5H).
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Figure 5. L4-stage H. contortus propidium iodide (PI) cell death staining (20× inverted scope)
following 2 days of treatment with (A) staurosporine (25 µM), demonstrating an intestinal-focused
cell death pattern; (B) MT4 (500 µM) demonstrating death of genital primordia cells, not visible in BB
staining; (C) ruxolitinib (500 µM), demonstrating cell death along the lateral line as well as cells in
the ventral cord; (D) leflunomide (500 µM), demonstrating widespread cell death including staining
of both the ANR and the PNR (PNR is not visible in BB live-cell staining); (E) sunitinib (500 µM),
demonstrating widespread cell death; (F) CID1067700 (500 µM), demonstrating an intestinal-focused
cell death pattern; (G) alvocidib (500 µM), demonstrating staggered intestinal nuclei patterning, and
(H) controls, demonstrating a lack of cell death in untreated L4 larvae.
Time course experiments evaluated PI staining in xL3 and L4 treated with NITs
(Figure 6), requiring at least five nuclei to be labeled for a positive score regardless of the
location of nuclei in the larvae. Use of the inverted microscope to assess labeling of larvae in
individual culture wells at 200× provided an efficient means to collect these data, whereas
transference to slides and viewing with DIC/fluorescent microscopy was neither reliable
nor efficient for this purpose. For xL3, PI labeled larvae generally accumulated to lower
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levels than L4s, with the possible exception of leflunomide, and only low accumulations
were observed with alvocidib, CID1067700, sunitinib, and ruxolitinib, all with means less
than 35% by day 4. In contrast, PI-labeled L4 accumulated to high levels with all NIT
treatments, except alvocidib, and leflunomide caused the most rapid response with a mean
<80% by day 1.
Figure 6. Time-course PI cell death assays for NITs of interest and untreated controls, for xL3 and L4
H. contortus larvae. All NITs were applied with a concentration of 500 µM except Staurosporine at 25 µM.
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Next, we evaluated the relationship between movement and PI staining in these assays
across NITs (Figure S2) and larval stages. While recognizing the lower sensitivity of xL3s
indicated in both assays, a general, but not exclusive, observation is that NITs induced
immotility that tended to precede detectable PI labeling (points below the diagonal). A
delay the in detection of cell death was most extreme for MT4 in xL3. Exceptions to this
association included leflunomide (xL3, L4) and MT4 (L4, but not xL3) treatments, both
of which caused high inhibition of motility and PI labeling within 24 h. CID1067700
was the only NIT that regularly produced PI labeling at higher levels than immotility for
L4, but not xL3. Consequently, the relationship between motility and detection of cell
death is complex, and the combination of responses related to immotility, PI detected cell
death and cells affected, and larval stage investigated produced unique profiles for each
given NIT. The data extends findings on correlation between PI labeling and motility for
H. contortus larvae [11], and indicate that information gained from the PI cell death assay
adds substantial information to that obtainable from motility assays alone.
2.5. Transcriptional Response of H. contortus Larvae to Selected NITs, Differentially Expressed
Genes and Enriched Pathways
In order to profile the transcriptional responses of xL3 and L4 larval stages of H.
contortus to NIT exposure, RNA-seq datasets were produced following 2 h of treatment
with leflunomide (500 µM), staurosporine (25 µM), CID106770 (500 µM), and DMSO
control treatments, in triplicate for both stages. The choice of exposure time and NIT
selection was based on maintaining consistency with our similar previous NIT RNA-seq
experiments in A. suum [4], with the goal of identifying immediate NIT-responsive gene
sets before downstream stress-response pathways were activated. Sequencing produced an
average of 40.9 million reads, with an average of 73.7% mapping to the genome, following
cleaning and processing (Supplementary Table S1A). Principal components analysis (PCA)
of RNA-seq datasets indicated substantial transcriptional differences between xL3 and
L4 H. contortus, regardless of NIT treatment (Figure 7A). Looking at the second and third
PCA components, leflunomide treatment produced the most consistent and substantial
transcriptional responses across both xL3 and L4, while CID1067700 treatment induced the
smallest overall transcriptional changes, consistent with the delayed motility phenotype
observed (Figure 3). DEseq2 differential expression analysis also supported these findings,
identifying the most genes significantly differentially expressed for leflunomide (380 genes
in xL3, 199 genes in L4) and staurosporine (1669 genes in xL3, 129 in L4), while very few
genes were differentially expressed for CID106770 (18 genes in xL3, no genes in L4). All
gene annotations, read counts, normalized expression values, and differential expression
statistics are available in Supplementary Table S1B.
Next, we identified the most significantly enriched KEGG pathways among the dif-
ferentially expressed genes in both xL3 and L4 stages, using gene set enrichment analysis
(GSEA) [18]. Due to the lack of differential expression observed for CID1067700, no path-
way enrichment for both larval stages was observed for this NIT. The most significantly
enriched pathway among genes upregulated by leflunomide treatment in both stages
(Table 1) was “citrate cycle (TCA cycle)”, and the top pathways among the genes downreg-
ulated by leflunomide (Table 2) included “Protein processing in endoplasmic reticulum”
and “MAPK” signaling. Following staurosporine treatment, the most significantly en-
riched pathways among the upregulated genes in both stages (Table 3) included “signaling
pathways regulating pluripotency of stem cells”, “Phosphatidylinositol signaling system”,
and “Inositol phosphate metabolism”, while the most significantly enriched pathways
among the downregulated genes (Table 4) included “Fatty acid elongation” and “Ether
lipid metabolism”.
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Figure 7. Principal components analysis (PCA) of RNA-seq datasets based on transcriptional profiles for xL3 and L4
H. contortus samples. Plots are shown for (A) principal components 1 and 2, and (B) principal components 2 and 3.
















20 Citrate cycle (TCA cycle) 2.01 5.3 × 10−5 1.93 5.5 × 10−4 - -
4630 Jak-STAT signalingpathway 1.92 3.0 × 10
−4 1.69 6.0 × 10−3 - -
4714 Thermogenesis 2.25 <1 × 10−5 1.57 1.6 × 10−2 - -
3050 Proteasome 1.77 1.5 × 10−3 1.80 4.1 × 10−3 - -
280 Valine, leucine andisoleucine degradation 1.76 1.7 × 10
−3 1.75 4.0 × 10−3 - -
4141 Protein processing inendoplasmic reticulum 2.06 <1 × 10
−5 1.89 1.4 × 10−3 Y -
4137 Mitophagy-animal 1.92 3.2 × 10−4 2.07 <1 × 10−5 Y -
3040 Spliceosome 1.92 3.4 × 10−4 2.37 <1 × 10−5 Y -
4530 Tight junction 2.14 <1 × 10−5 1.88 1.7 × 10−3 - Y
4068 FoxO signaling pathway 1.94 2.4 × 10−4 1.77 4.2 × 10−3 - Y
4371 Apelin signaling pathway 1.90 3.2 × 10−4 1.68 6.4 × 10−3 - Y





1.96 2.8 × 10−4 1.96 2.1 × 10−2 - Y
4152 AMPK signaling pathway 1.80 1.1 × 10−3 1.63 1.0 × 10−2 Y Y
4212 Longevity regulatingpathway-worm 1.83 7.7 × 10
−4 1.60 1.3 × 10−2 Y Y
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1.77 3.7 × 10−3 1.65 1.0 × 10−2 - -
360 Phenylalaninemetabolism 1.67 8.9 × 10
−3 1.76 3.5 × 10−3 - -
3018 RNA degradation 1.86 1.7 × 10−3 1.55 2.3 × 10−2 - -
4136 Autophagy-other 1.66 9.6 × 10−3 1.83 1.7 × 10−3 - -
4150 mTOR signaling pathway 1.66 9.5 × 10−3 1.71 5.7 × 10−3 - -
561 Glycerolipid metabolism 1.62 1.3 × 10−2 1.69 6.7 × 10−3 - -
4721 Synaptic vesicle cycle 1.53 2.3 × 10−2 1.65 9.6 × 10−3 - -
4137 Mitophagy-animal 1.74 5.1 × 10−3 1.80 2.3 × 10−3 Y -
4212 Longevity regulatingpathway-worm 1.61 1.3 × 10
−2 1.51 3.2 × 10−2 Y -
4152 AMPK signalingpathway 1.59 1.4 × 10
−2 1.54 2.5 × 10−2 Y -
3022 Basal transcriptionfactors 2.22 <1 × 10
−5 1.50 3.5 × 10−2 - Y
250 Alanine, aspartate andglutamate metabolism 1.88 1.5 × 10
−3 1.46 4.6 × 10−2 - Y
3010 Ribosome 1.54 2.1 × 10−2 2.77 <1 × 10−5 - Y
3040 Spliceosome 1.95 5.3 × 10−4 2.46 <1 × 10−5 Y Y
4141 Protein processing inendoplasmic reticulum 1.57 1.7 × 10
−2 1.98 2.1 × 10−4 Y Y












4550 Signaling pathways regulatingpluripotency of stem cells 1.82 1.1 × 10
−3 1.60 1.7 × 10−2 -
4926 Relaxin signaling pathway 1.78 1.5 × 10−3 1.60 1.7 × 10−2 -
4070 Phosphatidylinositolsignaling system 1.83 9.4 × 10
−4 1.55 2.0 × 10−2 -
4012 ErbB signaling pathway 1.73 2.3 × 10−3 1.61 1.7 × 10−2 -
4150 mTOR signaling pathway 1.89 5.1 × 10−4 1.53 2.3 × 10−2 -
562 Inositol phosphatemetabolism 1.64 5.2 × 10
−3 1.70 1.6 × 10−2 -
4721 Synaptic vesicle cycle 1.95 2.7 × 10−4 1.47 3.2 × 10−2 -
4310 Wnt signaling pathway 1.78 1.5 × 10−3 1.54 2.1 × 10−2 -
4212 Longevity regulatingpathway-worm 2.01 2.1 × 10
−4 1.67 1.5 × 10−2 Y
4010 MAPK signaling pathway 1.93 2.8 × 10−4 1.66 1.5 × 10−2 Y
4068 FoxO signaling pathway 2.00 1.8 × 10−4 1.61 1.7 × 10−2 Y
4723 Retrogradeendocannabinoid signaling 2.00 1.9 × 10
−4 1.56 2.0 × 10−2 Y
4371 Apelin signaling pathway 2.12 <1 × 10−5 1.53 2.3 × 10−2 Y
4152 AMPK signaling pathway 1.91 4.0 × 10−4 1.56 2.0 × 10−2 Y
4530 Tight junction 2.08 <1 × 10−5 1.44 3.8 × 10−2 Y
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650 Butanoate metabolism 2.00 1.8 × 10−4 1.61 1.7 × 10−2 -
3060 Protein export 2.12 <1 × 10−5 1.53 2.3 × 10−2 -
3008 Ribosome biogenesis ineukaryotes 1.78 1.5 × 10
−3 1.60 1.7 × 10−2 -
4744 Phototransduction 1.91 4.0 × 10−4 1.56 2.0 × 10−2 -
62 Fatty acid elongation 1.83 9.4 × 10−4 1.55 2.0 × 10−2 -
270 Cysteine andmethionine metabolism 1.73 2.3 × 10
−3 1.61 1.7 × 10−2 -
3420 Nucleotide excision repair 1.76 1.8 × 10−3 1.58 1.9 × 10−2 -
565 Ether lipid metabolism 1.89 5.1 × 10−4 1.53 2.3 × 10−2 -
30 Pentose phosphate pathway 2.08 <1 × 10−5 1.44 3.8 × 10−2 -
4146 Peroxisome 1.64 5.2 × 10−3 1.70 1.6 × 10−2 -
4141 Protein processing inendoplasmic reticulum 2.01 2.1 × 10
−4 1.67 1.5 × 10−2 Y
3040 Spliceosome 1.93 2.8 × 10−4 1.66 1.5 × 10−2 Y
250 Alanine, aspartate andglutamate metabolism 2.00 1.9 × 10
−4 1.56 2.0 × 10−2 Y
3022 Basal transcription factors 1.78 1.5 × 10−3 1.63 1.6 × 10−2 Y
3010 Ribosome 1.82 1.1 × 10−3 1.60 1.7 × 10−2 Y
3. Discussion
We explored the application of methods established with A. suum to rapidly determine
cell death in otherwise intact H. contortus larvae in culture following treatments with seven
different NITs. To the extent accomplished, the application has now been established for
representatives of two phylogenetic lineages (H. contortus, clade V; A. suum, Clade III) of
the Nematoda, while also revealing multiple differences in the performance of the assay
between the two different parasites, as will be discussed. The term nematode intestinal tox-
ins/toxicants (NITs) reflects the original focus of research to establish practical approaches
that kill intestinal cells of parasitic nematodes [3]. However, and not surprisingly, results
obtained with A. suum and now H. contortus indicated that multiple NITs individually cause
cell death in many tissues and cells beyond the intestinal tract, which demonstrates broader
application of the original research focus. To investigate potential cellular target proteins
and early pathways that may converge on cell death pathways, GRPs of H. contortus larvae
to three selected NITs were evaluated. Some H. contortus gene responses resembled those
found in A. suum and suggested potential cell targets, particularly for leflunomide.
3.1. Rapid Determination of Cell Death in H. contortus
The methods used to detect cell death and assign dead cells to specific cell types or or-
gan systems has clear application to H. contortus in otherwise intact L4 and xL3 maintained
in culture. The collection of cells documented as undergoing cell death varied among NITs,
indicating specificity of outcome attributable to each NIT. For instance, treatments with
some NITs led to PI nuclear staining primarily in intestinal cells [4], while for others (for
example, leflunomide, sunitinib, and MT4) cell death was detected in many tissues and
cells. As with A. suum, PI nuclear staining in whole H. contortus xL3 and L4 indicates: (1)
the ability of a given treatment to induce cell death, for which rapid methods to resolve
individual cells in whole worms were only recently described for parasitic nematodes [4];
and (2) the capacity of individual cells to undergo cell death, which, once achieved, is a
terminal status and one of interest for anthelmintic research. The very broad extent of PI la-
beling induced by treatments with leflunomide, sunitinib, and MT4 establishes that many if
not all cells of H. contortus L4, in particular, are susceptible to pharmacologic inducement of
cell death pathways, making knowledge of mechanisms involved relevant to anthelmintic
research. Treatment with other NITs cause more restricted PI staining, thus potentially
providing experimental tools selective for more restricted cell and organ populations. The
intestine, the target tissue for the initial prioritization of the NITs, appears to be more
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specifically targeted by the most effective NIT, staurosporine, as well as by CID1067700
and alvocidib. That individual cells or organs warrant attention for anthelmintic strategies
is supported by evidence that excretory/secretory cells in microfilaria of Brugia pahangi
are an apparent individual cell target for ivermectin [19], and intestinal cells of multiple
parasitic nematodes are crucial anthelmintic targets for benzimidazole anthelmintics [2].
Another notable finding is that some treatments caused apparent neuronal degeneration,
which is a more extreme pathologic response than interference with neurotransmission,
an endpoint achieved by numerous extant anthelmintics. A similar end point for neurons
was noted for A. suum [4]. Thus, with specific neurons identified coupled with treatments
that cause their degeneration and a means to detect that endpoint, valuable tools are now
available to investigate mechanisms involved. Similar logic is applicable to cells identified
as undergoing cell death in other organ systems.
However, an important caveat to use of PI on whole nematodes rather than cells in
culture relates to potential false negative PI staining. In this case, cells may die but go
undetected by PI staining due to the lack of access of PI to the damaged cell in whole worms,
as discussed previously [4]. PI must gain access across the cuticle, gut, or other access
points in order to stain nuclei of dead cells within the nematode. With this caveat in mind,
care is needed relative to questions investigated, experimental designs, and interpretations
of results with PI staining in whole nematodes. Equally important, though, is that the
caveat does not apply to positive results, which confirms access of PI to the affected cell
by virtue of nuclear labeling. With an assay that detects cell death, cellular mechanisms
(targets and pathways) responsible for this outcome might be investigated with other
treatments (inhibitors) designed to prevent cell death based on targets annotated for NITs,
e.g., cell pathways impacted by NITs (RNAseq) and mediators of cell death known in
other organisms, including nematodes [20]. A reason for interest in these mechanisms
stems from the fact that cell death is pharmacologically targeted in treatments of other
diseases [21,22] and might provide useful targets in anthelmintic strategies.
3.2. Comparisons of Microscopy and NIT Responses between H. contortus and A. suum
3.2.1. Cell and Organ Assessments
Despite this successful application of new methods to H. contortus, interspecies com-
parisons indicated that characteristics of A. suum larvae supported better resolution of
details on pathologic effects. As one example, better performance was evident in the far
more comprehensive live BB staining and DIC resolution of organs and cells in A. suum
L3 and L4. The number and range of nuclei labeled by BB in live H. contortus was more
restricted and similar in pattern for both xL3 and L4. Notable absences of, or restrictions on,
staining in H. contortus larvae included nuclei of cells posterior to the nerve ring, intestinal
cells, and many ventral chord nuclei of prospective hypodermal cells and neurons. A. suum
L3 and L4 both feed, and while only H. contortus L4 feed (xL3 do not), restrictions on
staining were similar for both H. contortus stages. Thus, differences in feeding competence,
and internal delivery of BB by ingestion, does not alone explain the differences in BB
staining between the two species. The results suggested that unknown physical differences
possibly related to cuticular and/or cell membrane constituents differentially impede BB
access to specific sites in H. contortus compared with A. suum larvae.
Resolution of cell and organ anatomy by DIC was also somewhat compromised in H.
contortus larvae. BB was used in conjunction with DIC to resolve anatomy with substantial
clarity in A. suum larvae. Thus, the limited scope of BB staining, light refraction by intestinal
inclusions that obscured detail for DIC microscopy, and a perceived less-distinct differenti-
ation of cells by DIC with H. contortus larvae together translated into comparatively lower
resolution of anatomical structures. Coupled with these challenges, the smaller larvae of
H. contortus also lessened confidence in assigning PI labeled nuclei to specific cells and
organs in many cases (although not all, see Figure 5) when viewed at a magnification
conducive for efficient counting of tens of larvae in replicate wells (20× objective, inverted
microscope). In sum, while the success in application of the methods to H. contortus of-
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fers optimism for utility with other parasitic nematodes, the interspecies differences also
indicate that specifics of the application could vary considerably among species.
3.2.2. NITs
We extended the list of NITs to include an inhibitor of p38 MAP kinases (MT4), which
inhibited larval movement in A. suum and caused demonstrable intestinal cell damage,
thus meeting the definition of a NIT established in this species. MT4 also was effective
against H. contortus in motility and PI nuclear staining assays. That p38 MAP kinases are
candidate targets for anthelmintics was also established in Brugia malayi [23], but not in
relation to specific nematode cells or organs.
The target proteins ascribed for each NIT in mammalian cells are largely distinct
among the NITs (summarized in [3]). Detrimental effects resulted from treatment of
H. contortus larvae by way of immotility and cell death for each NIT, thus suggesting that
these outcomes can be initiated through disruption of multiple distinct targets of NITs
in nematode cells. A balancing view is that the actual targets of NITs in A. suum and
H. contortus remain unknown and NITs have regularly been used in our experiments
at relatively high concentrations to obtain positive results from which to work toward
mechanisms of anthelmintic effects. Target proteins of several of the NITs include kinases
and elements of signal transduction pathways, and categorically similar inhibitors have
shown efficacy against H. contortus larvae [24], inclusive of demonstrable phenotypes
beyond motility [25]. It is also unclear if the target for an individual NIT is the same among
all affected cells, such as those identified by PI staining. Still, differences in PI staining
patterns observed among different NIT treatments support that perturbation of multiple
different targets can lead to the outcome of cell death in both H. contortus and A. suum.
In this regard, while NITs may or may not represent prospective anthelmintics, it seems
clear that they do represent experimental tools to investigate nematode cellular targets
and pathways that lead to the anthelmintic outcome of cell death in two phylogenetically
distant species, H. contortus and A. suum.
3.2.3. Gene Response Patterns
Gene response patterns (GRPs) can provide information relevant to target proteins
and pathways influenced by toxic treatments of cells [4]. GRPs to NIT treatments also
support that different NITs initiate effects via different targets and cell pathways. For
instance, GRPs to selected NITs (leflunomide, staurosporine, and CID1067700) showed
marked differences in A. suum L4 [4].
In humans, leflunomide targets only dihydroorotate dehydrogenase (DHODH) at
lower doses, with some inhibition of tyrosine kinases at higher doses [26]. Among the
pathways upregulated by leflunomide in both xL3 and L4 of H. contortus, the most sig-
nificant enriched pathway was “citrate cycle (TCA cycle)”, which was also identified as
the second-most enriched pathway after 2 h of leflunomide exposure in L3 A. suum [4].
DHODH links cellular respiration (including the TCA cycle) with pyrimidine synthesis [27],
so this pathway may indicate compensation for leflunomide’s indirect downstream effects.
Several pathways were enriched both among the genes most significantly upregulated and
among the genes most significantly downregulated with leflunomide, including “Protein
processing in endoplasmic reticulum”, a pathway previously shown to be disrupted and
differentially expressed in response to leflunomide treatment in cancer cells [28], along
with the activation of “MAPK signaling”, which we identified here as being upregulated
by both leflunomide and staurosporine, indicating more general NIT responsiveness. The
same study [28] also identified enrichment of the Jak-STAT signaling pathway following
leflunomide treatment in cancer cells, which was the second-most upregulated pathway in
this study. In addition, the pathways “thermogenesis” and “valine, leucine and isoleucine
degradation” identified as being upregulated in response to leflunomide were also upregu-
lated in our previous study of L3 A. suum [4]. Although no direct link is obvious between
these pathways and leflunomide activity, “valine, leucine and isoleucine degradation” may
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be linked to the described alterations in the TCA cycle, due to its production of propionyl
CoA which enters the TCA cycle at the succinyl CoA step [29]. Overall, the pathways identi-
fied here indicated that leflunomide has similar transcriptional-level effects on H. contortus
as for A. suum, and as previously described in mammalian cell models. These results, again,
are consistent with DHODH as a candidate target whose perturbation by leflunomide
might initiate cellular pathways leading to cell death. The ability to induce RNAi with
dsRNA treatments (reviewed in [30]) could facilitate investigations on this hypothesis.
The most significantly enriched KEGG pathway among the genes upregulated by
staurosporine treatment (Table 3) was “signaling pathways regulating pluripotency of stem
cells”, a mechanism directly supported by previous research showing that staurosporine
regulates lineage choice in pluripotent cells by acting as a broad-spectrum inducer of
molecular gastrulation [31]. The other pathways only enriched among genes upregulated
by staurosporine treatment include “Phosphatidylinositol signaling system” and “Inositol
phosphate metabolism”, pathways which were shown to be affected by staurosporine in
human platelets through the hydrolysis of phosphatidyl inositol 4,5-bisphosphate [32],
as well as “mTOR signaling pathway”, which was previously shown to be affected by
staurosporine through the inhibition of phosphorylation of mTOR transcriptional reg-
ulators [33]. Interestingly, “synaptic vesicle cycle” was upregulated by staurosporine,
which contains the “exocytosis” target pathway for which staurosporine was originally
prioritized as a NIT [3]. The pathways enriched only among the genes downregulated
by staurosporine (Table 4) include “Fatty acid elongation” and “Ether lipid metabolism”,
which may be related to the previously-described differential regulation of sphingolipids
in response to staurosporine treatment of cancer cells [34]. Here, we described several
staurosporine-regulated pathways in H. contortus that are consistent with results from
other studies. Nevertheless, the wide range of cellular effects known to be induced by
staurosporine complicates the identification of a specific molecular target.
Overall, several NIT-specific and shared GRPs were identified among NITs, which
were conserved across both xL3 and L4 stages. These shared pathway responses may reflect
more general stress responses, even though the early treatment timepoint (2 h) aimed to
minimize these general stress responses and cell death responses, in order to better elucidate
the NIT-specific responses. However, since CID1067700 was relatively slow-acting in terms
of motility inhibition and cell death (Figures 3 and 5), this 2-h timepoint seemed insufficient
to observe a consistent cellular GRP response. The identification of multiple unique cell
targets and affected pathways reflects the differences in NIT motility responses, as well as
the cell death assays showing unique NIT profiles. It should be noted that the H. contortus
xL3 larvae for the GRP analysis were obtained from a different laboratory-passaged strain
than the rest of the experimentation, but the results obtained here were consistent with
our previous A. suum study with a similar design, as well as with existing literature
describing cellular responses to these NITs, indicating broad phylogenetically consistency
in application of methods and responses to NITs. However, the phylogenetic levels at
which differences emerge is not known and could include interstrain variability. Overall,
our results highlighted that the NITs have unique and complex mechanisms of action that
do not simply immediately result in cellular death.
4. Materials and Methods
4.1. Ethics Statement
All animal experiments were carried out under protocols approved by Washington
State University Institutional Animal Care and Use Committee, protocol 4097. The proto-
cols meet requirements of AVMA Guidelines for the Euthanasia of Animals: 2013 Edition;
Guide for the Care and Use of Laboratory Animals: 2011 Edition, National Research Coun-
cil, and USA Animal Welfare Act and Animal Welfare Regulations: 2017 Edition (AWA),
US Department of Agriculture.
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4.2. Haemonchus contortus L3, L4 and Adults
Haemonchus contortus L3 larvae were obtained from two sources; small batches of
laboratory-passaged L3 were purchased from Dr. Ray Kaplan (University of Georgia,
Department of infectious diseases, Athens, GA, USA) and used in most experiments
presented here, and large batches (1 to 2 million) of laboratory-passaged L3 provided by
Zoetis (Dr. Debra Woods, Global Parasitology Research at Zoetis, Kalamazoo, MI, USA)
were used to determine gene transcript responses to experimental treatments. Isolates from
both sources were designated as susceptible to contemporary anthelmintics. Exsheathed L3
(xL3) were produced by incubation of L3 in 0.125% sodium hypochlorite at 37 ◦C for twenty
minutes. xL3 were washed 5 times in sterile phosphate buffered saline (pH 7.4) by pelleting
larvae at 600× g for five minutes, discarding the supernatant, and then adding PBS for the
next rinse. After the final rinse, pelleted xL3 were resuspended in RPMI medium (R8758,
Sigma-Aldrich, St. Louis MO) containing 20% fetal bovine serum, 100 units penicillin, and
100 µg Streptomycin per mL (P0781, Sigma-Aldrich, St. Louis, MO, USA) and incubated at
38 ◦C with 20% CO2. L4 were generated by incubation of xL3 in this conditioned media
for 7 days. Acquisition of L4 characteristics (well-defined mouth) was observed by this
time in a mean 95.3% (±1.3%) of larvae. Culture volumes were 100 µL in 96 well plates
(3595, Costar, Corning Inc., Corning, NY, USA) and 1 mL in 24 well plates for applications
in this research.
4.3. Ascaris suum L3, L4
A. suum lung-stage L3 were obtained as described before [3]. Briefly, infective larvated
eggs were used from batches generated from previous studies [3,4]. Then, 4000 eggs were
used to orally infect New Zealand white rabbits (5.5 to 6.5 weeks old, Western Oregon
Rabbit Company, Philomath, OR, USA) and L3 were collected from the lungs by lavage.
Larvae were settled by gravity and then washed in 3 sequential 50 mL volumes of warm
PBS followed by 3 sequential 15 mL volumes, with intervening gravity sedimentation
and discard of supernatant PBS. Extracted and cleaned larvae were then suspended in
RPMI medium (R8758, Sigma-Aldrich, St. Louis, MO, USA, containing 10% swine serum,
100 units penicillin and 100 µg Streptomycin/mL; P0781, Sigma-Aldrich, St. Louis, MO,
USA) and then, if used for testing as L3, dispensed into wells of 96-well plates (3595, Costar,
Corning Inc., Corning, NY, USA, triplicate wells for each treatment), with a total volume of
100 µL culture medium containing treatments with diluent (DMSO, 922401 JT Baker, Center
Valley, PA, USA) at 1%. L3 were then incubated at 37 ◦C in 5% CO2 for times prescribed for
each experimental design. Alternatively, to obtain L4, L3 were incubated in 1 mL culture
medium contained in a 15 mL polypropylene tube (62.554.100, Sarstedt, Newton, NC, USA)
with a loosened screw cap for 3 days, and medium was replaced daily with fresh medium.
L3 molted to L4 by day 3. L4 generated in this way were dispensed into wells of 96 well
plates used for experiments described here and incubated as for L3.
4.4. Fluorescent Marker Labeling
To determine the ability of xL3 and L4 H. contortus to ingest fluorescent probes, two
function-based fluorescent probes were used in feeding assays: (1) beta-ala,lys-AMCA
(BAL-AMCA), 200 µM (BP0352, BioTrend, Zurich, Switzerland) [12]; and (2) DQ Green-BSA
(D-12050, Molecular Probes, Eugene, OR, USA), 100 µg/mL [13]. L3 and L4 were cultured
in the presence of these probes for 4 h prior to assessment of ingestion. To assess staining
of nuclei by bisbenzimide (BB, 10 µg/mL, H 33258, Sigma-Aldrich, St. Louis, MO, USA)
live xL3 and L4 were incubated with BB in standard culture conditions for 16 h prior to
assessment by fluorescent microscopy. To assess cell death in whole xL3 and L4, propidium
iodide (PI, P4170, Sigma-Aldrich, St. Louis, MO, USA) was used at 100 µM, and added to
larval cultures 4 h prior to the addition of experimental treatments. Preincubation leading
to ingestion of PI was intended to maximize access of tissues to the fluorescent probes in
presence of various treatments.
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4.5. Microscopy and Imaging
Fluorescent labeling of larvae in wells of 96 well plates was monitored using a Nikon
Diaphot 300 inverted microscope equipped with epifluorescence capabilities: UV-2A filter
(blue), BB, BAL-AMCA; G1A (red filter), PI; B2A (green filter), DQ-BSA) and recorded with
a Nikon D5100 digital camera. Most observations were made using the 20× microscope
objective (200× magnification). To better resolve cells and organs in which BB-stained
nuclei reside, larvae were transferred from wells and placed onto agar pads on glass
microscope slides and viewed using the 60× microscope objective (600× magnification) on
a Nikon Optiphot compound microscope equipped with differential interference contrast
(DIC) filters, epifluorescence capabilities, and a Nikon D5100 digital camera. To optimize
resolution of DIC/fluorescence details, images were captured in movie mode, and then
selected screen shots were copied and used to produce final digital images.
4.6. NIT Treatments
A set of chemicals identified as nematode intestinal toxins/toxicants (NITs) [3] were
used in experiments here and included: alvocidib (S1230), sunitinib (S7781), Selleckchem
Houston, TX, USA; CID1067700 (SML054), leflunomide (L5025), p38 MAP kinase inhibitor
IV (a.k.a. MT4, which was used in this paper, SML0543) Sigma-Aldrich, St. Louis, MO,
USA; ruxolitinib (tlrl-rux), InvivoGen, San Diego, CA, USA; staurosporine (S-9300), LC
Laboratories, Woburn, MA, USA. DMSO was used as diluent for chemical treatments,
except propidium iodide was solubilized in PBS, and concentrations were adjusted to
achieve a maximum 1% DMSO after all components were included for each experiment.
Control wells were adjusted according to diluent used for treatment wells. With the
exception of staurosporine, treatments were initiated at 500 µM (staurosporine, 25 µM)
to better ensure the possibility of achieving a positive result with PI labeling based on
previous experience [3]. Dose response experiments to determine effective dose 50 (IC50)
were conducted using two-fold serial dilutions over a range of 5 concentrations. IC50
values were calculated using AAT Bioquest (Sunnyvale, CA, USA) IC50 calculator (https:
//www.aatbio.com/tools/IC50-calculator/ (accessed on June 17 2021)).
4.7. Motility PI labeling Assays
xL3 and L4 were dispensed into triplicate wells of 96 well plates containing more than
twenty larvae each, in 100 µL of medium containing treatments. Movement was scored
using the inverted microscope, and 200× magnification. Plates were agitated manually to
encourage movement of larvae and larval movement was scored if observed during an
approximate 45 sec observation period. Mean motility for each treatment was determined
for each day over the course of 4 days. The setup for PI labeling assays was identical,
except that wells also contained PI and BB, and PI labeling was scored with the inverted
fluorescent microscope using 200× magnification. A conservative PI scoring system was
used in that more than 5 nuclei labeled with PI in a given larva were required to be scored
positive. The mean number of PI positive larvae was determined for each treatment, each
day, over a course of days.
4.8. RNA Extraction, RNA-seq and Differential Expression Analysis
For RNAseq analysis (see below), approximately 80,000 H. contortus xL3 or L4 were
aliquoted into each of triplicate wells in a 48 well plate and 1 mL of media for each treat-
ment. The treatments included leflunomide (500 µM), staurosporine (25 µM), CID1067700
(500 µM), or diluent (1% DMSO) followed by incubation for 2 h, then rinsing with three
1 mL volumes of PBS (7.4), withdrawing excess PBS and mixing larval pellets with 50 µL
TRIzol (Invitrogen/Life Technologies, Carlsbad, CA, USA), and then freezing samples at
−80 ◦C until processed for RNA. RNA was extracted from pellets of untreated and treated
larval H. contortus frozen in Trizol (described under Section 2.5) for RNAseq analysis by
homogenizing larval pellets as they thawed using a microfuge pestle, and then processing
TRIzol extracts according to the manufacturer’s instructions. Ethanol pellets of isolated
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RNA were shipped to Washington University for further processing and sequencing. RNA-
seq analysis was performed as previously described for Ascaris suum [4]. Briefly, cDNA
libraries were prepared from RNA samples using the Clontech SMARTer universal low-
input RNA kit to maximize yield and processed cDNA was sequenced on the Illumina
NovaSeq S4 platform (paired-end 150bp reads). Trimmomatic v0.36 [35] was used to trim
adapters, and the STAR aligner [36] (v2.7.3a; 2-pass mode, basic) was used to map RNA-
seq reads to the H. contortus genome assembly (PRJEB506.WBPS14 [37]), which were then
counted for every annotated protein-coding gene in the assembly using featureCounts [38].
DESeq2 [39] was used to perform differential expression comparisons, comparing each
NIT the control samples collected for both xL3 and L4-stage larvae. Principal components
analysis (PCA) was carried out using DESeq2 output (default settings). The raw RNA-seq
read files (fastq) are accessible on the NCBI Sequence Read Archive (SRA [40], BioProject
PRJNA264197), and complete sample metadata, read counts, normalized expression values,
and accession information are provided in Supplementary Table S1.
H. contortus genes based on the PRJEB506.WBPS14 annotation and assembly [37]
were assigned functional annotations using both InterProScan v5.42 [41] to identify gene
ontology assignments as well as InterPro domains, and GhostKOALA v2.2 [42] to as-
sign KEGG annotations. Potentially secreted proteins were identified using both SignalP
v5.0 [43] for signal peptides and transmembrane domains, and SecretomeP v2.0 [44] to
identify proteins with non-classical secretion sequences. Gene set enrichment analysis
(GSEA [18]) was performed, based on DESeq2 differential expression results, to test for
enrichment among non-human KEGG pathway annotations using WebGestalt v2019 [45]
(FDR-adjusted p ≤ 0.05, minimum 5 genes differentially expressed). The input values for
GSEA analysis were the ranks (largest value to smallest) of the genes when ranked based
on (a) differential expression p value from DESeq2 analysis, following log transformation,
where upregulated genes were calculated using negative log, and downregulated genes
were calculated using positive log, and (b) Log2 fold change value when p values were
tied. The top 15 most significantly enriched KEGG pathways shared between both xL3
and L4 for each NIT were identified (according to FDR-adjusted p values). “Normalized
enrichment scores” shown in Tables 1–4 were the primary statistic calculated by Gene Set
Enrichment Analysis to evaluate results, and represent the degree to which a gene set is
overrepresented at the top or bottom of a ranked list of genes, normalized for differences
in gene set sizes (since smaller gene sets are more likely to all be close to the top of a list by
random chance).
5. Conclusions
This study presented an interdisciplinary approach designed to intersect (i) methodol-
ogy that comprehensively resolved, in whole unfixed parasites, NIT-induced pathology
among most cells and organs in H. contortus, and (ii) interrogation of transcriptional re-
sponses to NIT treatments, resulting in the identification of their putative molecular targets
and pathways. The assays directly identified the constellation of cells and organ systems
that undergo cell death with respect to each of multiple chemical toxins/toxicants. Suscep-
tibility to inducible cell death adds rationale to investigate the cells and organs identified in
anthelmintic research, and advances established here provided new experimental methods
to do so. We also identified, for some NITs, cellular pathways and molecular targets that
are potential antecedents to irreparable pathologic outcomes. Our original derivation of
NITs involved a de novo approach [3] which, when building on methodology we have
developed [4] and integrated with results described here, establish a unique and useful
experimental system for the purposes of discovery and detailed analysis of anthelmintic
compounds and investigation of mechanisms of their toxicity. Ultimately, knowledge of
mechanisms that actually mediate cell death coupled with pathways whose disruption
initiate death processes hold much potential for application in anthelmintic research. The
results shown here confirmed cross-species efficacy of the NITs, which were computation-
ally predicted to have broad efficacy across nematodes. In addition to their previously
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demonstrated efficacy against A. suum, an important parasite of humans, our results demon-
strated efficacy against species of a great veterinary importance, the blood feeding parasitic
nematode of small ruminants H. contortus. In the future, the efficacy of these NITs may also
be tested to other parasitic nematodes of economic and clinical importance, including as
plant or aquatic parasitic nematodes, given that here, we demonstrated consistent efficacy
spanning multiple nematode clades.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ph14070598/s1, Figure S1: IC50 values for all NITs in L4-stage H. contortus, at days 1 to 4;
Figure S2: Association between motility inhibition and PI staining for each of the seven NITs. All
NITs were applied with a concentration of 500 µM except Staurosporine at 25 µM. PI was applied
4 h pre-treatment and included throughout the treatment period; Supplementary Table S1: RNA-seq
data, including (A) Metadata and read count statistics for all RNA-seq samples and (B) Functional
annotations, mapped RNA-seq read counts, FPKM relative expression values, and DESeq2 differential
expression results for all genes and all RNA-seq samples.
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